期刊文献+

HPV16-E6/E7在尖锐湿疣患者癌前病变分级诊断中的作用分析 被引量:1

Diagnosis value of HPV16-E6/E7 in precancerous lesions grading for patients with condyloma acuminatum
原文传递
导出
摘要 目的 评价HPV16-E6/E7在尖锐湿疣患者癌前病变分级诊断中的作用.方法 将2013年12月-2014年12月来本院就诊的100例尖锐湿疣患者作为研究对象,采集所有患者的宫颈口样本,利用进行26种HPV基因亚型检测以及HPV16-E6/E7的基因检测.根据HPV 16-E6/E7在不同病变分级中检出率的不同,分析其中临床诊断中的提示作用.结果 HPV总检出率为24.0%(24/100),其中高危型(HPV 16、HPV18、HPV31、HPV33、HPV35、HPV39、HPV45)、低危型(HPV6、HPV 11、HPV40、HPV42、HPV44)和混合型(HPV 16和HPV11、HPV33和HPV40)检出率分别为17.0% (17/100),5.0% (5/100)和2.0%(2/100).炎症组、CIN组、癌症组HPV 16-E6检出率分别为5%、20%、30%,三者检出的差异显著(P<0.05);HPV16-E7检出率分别为50%、65%、79%,三者检出的差异有统计学意义(P<0.05).结论 HPV 16-E6/E7基因与宫颈疾病及其癌变的关系密切. Objective To analysis precancerous lesion grading value of HPV16 E6 / E7 in the diagnosis of patients with condyloma acuminatum.Methods 100 patients confirmed with genital warts were selected as research objects from December, 2013 to December 2014.Cervical epithelium samples were obtained from all patients and detected for HPV genotyping and HPV16-E6/E7.The diagnosis value was analyzed based on the results of HPV16-E6/E7 in different pathology grades.Results The total detection rate of HPV was 24.0% (24/100) and the positive rate of high-risk (HPV 16, HPV18, HPV31, HPV33, HPV35, HPV39, HPV 45), low-risk type (HPV6, HPV11, HPV40, HPV 42, HPV44) and mixed type (HPV 16 and HPV11,HPV33 and HPV40) were 17.0% (17/100), 5.0% (5/100) and 2.0% (2/100), respectively.The detection rates of HPV 16-E6 in inflammation group, CIN group, Cancer group were 5%, 20%, 30%, respectively.There was significant difference between three groups (P 〈 0.05).The detection rates of HPV16-E7 in three groups were 50%, 65%, 79%, respectively.The difference was significant (P 〈0.05).Conclusions HPV 16-E6/E7 gene were closely associated with cervical disease and cancerous.
作者 杨超 徐薇
出处 《国际病毒学杂志》 2015年第6期419-421,共3页 International Journal of Virology
关键词 人乳头瘤病毒 基因分型 宫颈上皮内瘤变 Human papilloma virus Genotyping Cervical intraepithelial neoplasia
  • 相关文献

参考文献17

二级参考文献156

  • 1牛晓宇,彭芝兰,王和.RNA干涉抑制宫颈癌CaSki细胞株HPV16 E6基因的研究[J].癌症,2004,23(11):1257-1262. 被引量:27
  • 2陈天波,张春和,丁世霖,张富刚,余发周.三种方法联合治疗男性复发性尖锐湿疣的临床观察[J].现代医药卫生,2006,22(7):980-981. 被引量:4
  • 3拉莱.苏祖克,彭玉华,周康,房新志,王莉.新疆不同民族子宫颈癌发病趋势分析[J].新疆医科大学学报,2006,29(7):569-571. 被引量:81
  • 4吴文中,刘姝莉,李延武,宋建明,张书岭.尖锐湿疣患者荧光定量PCR检测结果分析[J].中国艾滋病性病,2006,12(4):350-351. 被引量:17
  • 5Narisawa-Saito M, Kiyono T. Mechanisms of high-risk human papil- lomavirus-induced cervical carcinogenesis [ J ]. Nihon Rinsho, 2009,67 ( 1 ) :53-61.
  • 6Lee SK, Kumar P. Conditional RNAi : towards a silent gene therapy [J]. Adv Drug Deliv Rev, 2009,61 (7-8) :650-664.
  • 7Sima N, Wang S, Wang W, et al. Antisense targeting human papil- lomavirus type 16 E6 and E7 genes contributes to apoptosis and se- nescence in SiHa cervical carcinoma cells [ J ]. Gyneeol Oneol, 2007,106 ( 2 ) : 299-304.
  • 8Wu TC. Therapeutic human papillomavirus DNA vaccination strate- gies to control cervical cancer[ J]. Eur J Immunol, 2007,37 (2) : 310-314.
  • 9Ledwaba T, Dlamini Z, Naicker S, et al. Molecular genetics of hu- man cervical cancer: role of papillomavirus and the apoptotic cas- cade[J]. Biol Chem, 2004,385(8) :671-682.
  • 10Muggia FM. Recent updates in the clinical use of platinum com- pounds for the treatment of gynecologic cancers [ J ]. Semin Oncol, 2004,31 (6 Suppl 14) :17-24.

共引文献155

同被引文献7

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部